Covalon Technologies Ltd. (TSXV:COV)
1.790
-0.010 (-0.56%)
Mar 12, 2026, 3:22 PM EST
Covalon Technologies Market Cap
Covalon Technologies has a market cap or net worth of CAD 49.71 million as of March 12, 2026. Its market cap has decreased by -34.54% in one year.
Market Cap
49.71M
Enterprise Value
33.90M
Revenue
31.54M
Ranking
n/a
PE Ratio
52.37
Stock Price
1.79
Market Cap Chart
Since September 3, 2004, Covalon Technologies's market cap has increased from 3.06M to 49.71M, an increase of 1,523.16%. That is a compound annual growth rate of 13.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 49.71M | 4.20% |
| Dec 31, 2025 | 47.71M | -46.42% |
| Dec 31, 2024 | 89.04M | 240.51% |
| Dec 29, 2023 | 26.15M | -55.61% |
| Dec 30, 2022 | 58.91M | -14.07% |
| Dec 31, 2021 | 68.55M | 130.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Extendicare | 2.52B |
| Curaleaf Holdings | 2.39B |
| Sienna Senior Living | 2.29B |
| Green Thumb Industries | 2.04B |
| Ocumetics Technology | 54.45M |
| Leef Brands | 54.17M |
| NurExone Biologic | 52.64M |
| LSL Pharma Group | 49.09M |